We validated this approach in samples collected from patients with EWS, fusion-positive RMS, desmoplastic small round cell tumors (DSRCT) and small round blue cell tumors with non-EWS fusions, including the BCOR-CCNB3 fusion. This evidence concerns the gene CCNB3 and desmoplastic small round cell tumor.